Mir-7上调增强肺腺癌对吉非替尼敏感性的机制研究

合集下载
  1. 1、下载文档前请自行甄别文档内容的完整性,平台不提供额外的编辑、内容补充、找答案等附加服务。
  2. 2、"仅部分预览"的文档,不可在线预览部分如存在完整性等问题,可反馈申请退款(可完整预览的文档不适用该条件!)。
  3. 3、如文档侵犯您的权益,请联系客服反馈,我们会尽快为您处理(人工客服工作时间:9:00-18:30)。

Mir-7上调增强肺腺癌对吉非替尼敏感性的机制研究
作者:赵俊刚, 鲁继斌, 门万夫, 张磊, ZHAO Jungang, LU Jibin, MEN Wanfu, ZHANG Lei
作者单位:中国医科大学附属盛京医院胸外科,辽宁 沈阳,110004
刊名:
现代肿瘤医学
英文刊名:Journal of Modern Oncology
年,卷(期):2012,20(6)
1.Jemal A;Tiwari RC;Murray T Cancer statistics 2004(01)
2.Rusch V;Baselga J;Cordon-Cardo C Differential expression of the epidermal growth factor receptor and its ligands in primary.non-small cell lung cancers and adjacent benign lung 1993(10'Suppl)
3.Jiang L;Liu X;Chen Z MicroRNA-7 targets IGF1R(insulin-like growth factor 1 receptor) in tonguesquamous cell carcinoma cells 2010(01)
4.Kumar MS;Lu J;Mercer KL Impaired microRNA processing enhances cellular transformation and tumorigenesis 2007(39)
5.Prochnik SE;Rokhsar DS;Aboobaker AA Evidence for a microRNA expansion in the bilaterian ancestor 2007
6.Xin Li;Justin J;Cassidy A rnicroRNA imparts robustness against enviromental fluctuation during development 2009(02)
7.Sempere LF;Freemantle S;Pitha-Rowe I Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation
2004(03)
8.Farh KK;Grimson A;Jan C The widespread impact of mammalian microRNAs on mRNA repression and evolution 2005(5755)
ndgraf P;Rusu M;Sheridan R A mammalian microRNA expression atlas based on small RNA library sequencing 2007(07)
10.Bottoni A;Zatelli MC;Ferracin M;Tagliati F;Piccin D;Vignali C;Calin GA;Negrini M;Croce CM;Degli-Uberti EC Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.[外文期刊] 2007(2)
11.Gaur,A;Jewell,DA;Liang,Y;Ridzon,D;Moore,JH;Chen,C;Ambros,VR;Israel,MA Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.[外文期刊] 2007(6)
12.Yauch RL;Januario T;Eberhard DA Epidermal versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of elotinib in lung cancer patients 2005
13.Bruzzese F;Leone A;Rocco M HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib
in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT 2011(09)。

相关文档
最新文档